Stay updated with breaking news from Matthewb Klein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Review of European marketing application for PKU now initiated - WARREN, N.J., May 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. announced today that the sepiapterin MAA for PKU has been...
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average rating of “Hold” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have issued a buy recommendation on […]
PTC Therapeutics (NASDAQ:PTCT – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $43.00 to $53.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. A number of other brokerages also recently weighed in on PTCT. Cantor Fitzgerald reissued […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Research analysts at Leerink Partnrs dropped their Q2 2024 earnings per share estimates for shares of PTC Therapeutics in a report issued on Sunday, May 19th. Leerink Partnrs analyst J. Schwartz now forecasts that the biopharmaceutical company will earn ($1.02) per share for the quarter, down from […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Research analysts at Leerink Partnrs lowered their Q2 2024 earnings estimates for shares of PTC Therapeutics in a research report issued to clients and investors on Sunday, May 19th. Leerink Partnrs analyst J. Schwartz now expects that the biopharmaceutical company will earn ($1.02) per share for the […]